| 172.66 Delayed Data As of May 22 |  +0.66 / +0.38%Today’s Change | 134.38 Today|||52-Week Range 197.86 | +12.72% Year-to-Date |
| Orbimed Advisors Llc Buys Neurocrine Biosciences Inc, Teva Pharmaceutical Industries,... May 22 / GuruFocus NewsGURU - Paid Partner Content | HOLX vs. EW: Which Stock Is the Better Value Option? May 20 / Zacks.comZAK - Paid Partner Content |
| Edwards Announces Milestones For Transcatheter Mitral Program May 22 / PR NewswirePRN - Paid Partner Content | Bull of the Day: Penumbra (PEN) May 15 / Zacks.com - Paid Partner Content |
| Previous close | 172.00 |
| Today’s open | 171.19 |
| Day’s range | 171.00 - 173.95 |
| Volume | 1,076,528 |
| Average volume (3 months) | 1,293,507 |
| Market cap | $36.5B |
| Earnings growth (last year) | +24.55% |
| Earnings growth (this year) | +12.15% |
| Earnings growth (next 5 years) | +16.46% |
| Revenue growth (last year) | +8.37% |
| P/E ratio | 48.0 |
| Price/Sales | 8.79 |
| Price/Book | 11.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNNSmith & Nephew PLC | +0.27 | +0.64% |
| ISRGIntuitive Surgical | +1.81 | +0.37% |
| STESteris plc | +0.31 | +0.23% |
| HRCHill-Rom Holdings In... | +0.91 | +0.95% |
| Next reporting date | July 24, 2019 |
| EPS forecast (this quarter) | $1.32 |
| Annual revenue (last year) | $3.7B |
| Annual profit (last year) | $722.2M |
| Net profit margin | 19.40% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Michael A. Mussallem |
Chief Financial Officer & Vice President Scott B. Ullem |
Corporate headquarters Irvine, California |
